Related Experiment Video
Updated: Jul 11, 2026

08:22
Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
Published on: May 16, 2025
Copper and manganese induce yeast apoptosis via different pathways
1State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China.
Molecular Biology of the Cell
|September 21, 2007
Summary
Both copper and manganese induce apoptosis in yeast cells at toxic levels, with necrosis occurring at higher concentrations. Mitochondria and specific proteins mediate these metal-induced cell death pathways.
Area of Science:
- Cell Biology
- Toxicology
- Biochemistry
Background:
- Metal ions are crucial for cellular function but can also be toxic.
- The precise mechanisms underlying metal-induced cellular toxicity remain incompletely understood.
- Essential nutrients like copper (Cu) and manganese (Mn) can exhibit dual roles, being beneficial at low concentrations and toxic at higher levels.
Purpose of the Study:
- To investigate the apoptotic effects of copper and manganese in the yeast Saccharomyces cerevisiae.
- To elucidate the molecular pathways involved in copper- and manganese-induced apoptosis.
- To identify key cellular components and signaling molecules that mediate metal toxicity.
Main Methods:
- Utilized Saccharomyces cerevisiae as a model organism.
- Assessed apoptosis and necrosis induction by varying concentrations of copper and manganese.
- Employed mitochondria-defective yeast strains to evaluate mitochondrial involvement.
- Measured reactive oxygen species (ROS) production.
- Investigated the role of specific genes, including metacaspase Yca1p and cyclophilin D homolog Cpr3p, through genetic screening and mutant analysis.
Main Results:
- Both copper and manganese induced significant apoptosis in yeast cells at moderately toxic concentrations, with necrosis predominating at higher levels.
- Mitochondria-defective yeast showed reduced apoptosis and increased survival under metal stress, confirming mitochondrial involvement.
- Copper-induced toxicity was associated with high ROS generation, which was mitigated by superoxide dismutase 2 overexpression.
- Manganese-induced apoptosis, but not copper-induced apoptosis, involved the yeast metacaspase Yca1p.
- A genetic screen identified Cpr3p, a cyclophilin D homolog, as crucial for copper-induced apoptosis, with Cpr3p mutants resistant to copper-induced apoptosis.
Conclusions:
- Copper and manganese exhibit dose-dependent toxicity, inducing apoptosis and subsequently necrosis in yeast.
- Mitochondria play a central role in mediating both copper- and manganese-induced apoptosis.
- Reactive oxygen species are key mediators of copper toxicity, but not manganese toxicity.
- Distinct molecular pathways, involving Yca1p for manganese and Cpr3p for copper, are implicated in metal-induced apoptosis, offering insights into metal toxicity diseases.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Yeast Signaling
Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

